An Efficacy and Safety Study of Fremanezumab in Adults With Migraine

PHASE3CompletedINTERVENTIONAL
Enrollment

838

Participants

Timeline

Start Date

October 13, 2017

Primary Completion Date

October 2, 2018

Study Completion Date

May 29, 2019

Conditions
Migraine Prophylaxis
Interventions
DRUG

Fremanezumab

Fremanezumab will be administered per dose and schedule specified in the arm.

DRUG

Placebo

Placebo matching to fremanezumab will be administered per schedule specified in the arm.

Trial Locations (113)

1090

Teva Investigational Site 37089, Brussels

2600

Teva Investigational Site 39048, Glostrup Municipality

2750

Teva Investigational Site 39052, Ballerup Municipality

3010

Teva Investigational Site 45016, Bern

3500

Teva Investigational Site 37091, Hasselt

4000

Teva Investigational Site 37090, Liège

5330

Teva Investigational Site 45018, Bad Zurzach

6900

Teva Investigational Site 45017, Lugano

7100

Teva Investigational Site 39050, Vejle

8000

Teva Investigational Site 37092, Bruges

Teva Investigational Site 39049, Aarhus

9000

Teva Investigational Site 39051, Aalborg

10177

Teva Investigational Site 32697, Berlin

13005

Teva Investigational Site 35235, Marseille

14226

Teva Investigational Site 14753, Amherst

15706

Teva Investigational Site 31230, Santiago de Compostela

18147

Teva Investigational Site 32701, Rostock

20100

Teva Investigational Site 40032, Turku

20251

Teva Investigational Site 32698, Hamburg

20520

Teva Investigational Site 40037, Turku

21208

Teva Investigational Site 14747, Pikesville

24149

Teva Investigational Site 32700, Kiel

27405

Teva Investigational Site 14736, Greensboro

27408

Teva Investigational Site 14741, Greensboro

27607

Teva Investigational Site 14732, Raleigh

28223

Teva Investigational Site 31235, Madrid

28942

Teva Investigational Site 31236, Madrid

30030

Teva Investigational Site 14760, Decatur

31008

Teva Investigational Site 31226, Pamplona

32751

Teva Investigational Site 14758, Maitland

32819

Teva Investigational Site 14738, Orlando

35801

Teva Investigational Site 14742, Huntsville

37203

Teva Investigational Site 14743, Nashville

38119

Teva Investigational Site 14745, Memphis

38500

Teva Investigational Site 35236, Voiron

39008

Teva Investigational Site 31229, Santander

40223

Teva Investigational Site 14735, Louisville

41013

Teva Investigational Site 31234, Seville

44787

Teva Investigational Site 32694, Bochum

45147

Teva Investigational Site 32699, Essen

46010

Teva Investigational Site 31233, Valencia

46026

Teva Investigational Site 31227, Valencia

47003

Teva Investigational Site 31225, Valladolid

48104

Teva Investigational Site 14731, Ann Arbor

50009

Teva Investigational Site 31228, Zaragoza

50134

Teva Investigational Site 30199, Florence

51601

Teva Investigational Site 54157, Rychnov nad Kněžnou

53002

Teva Investigational Site 54158, Pardubice

55441

Teva Investigational Site 14748, Plymouth

59037

Teva Investigational Site 35238, Lille

60201

Teva Investigational Site 14740, Evanston

60607

Teva Investigational Site 14730, Chicago

61462

Teva Investigational Site 32695, Königstein im Taunus

67098

Teva Investigational Site 35239, Strasbourg

68114

Teva Investigational Site 14746, Omaha

69677

Teva Investigational Site 35237, Bron

70200

Teva Investigational Site 54159, Ostrava

73033

Teva Investigational Site 32692, Göppingen

78731

Teva Investigational Site 14733, Austin

80918

Teva Investigational Site 14749, Colorado Springs

81377

Teva Investigational Site 32689, München

83642

Teva Investigational Site 14737, Meridian

84088

Teva Investigational Site 14751, West Jordan

87102

Teva Investigational Site 14752, Albuquerque

89073

Teva Investigational Site 32693, Ulm

90100

Teva Investigational Site 40036, Oulu

90404

Teva Investigational Site 14843, Santa Monica

90806

Teva Investigational Site 14729, Long Beach

92103

Teva Investigational Site 14739, San Diego

02720

Teva Investigational Site 14750, Fall River

02472

Teva Investigational Site 14734, Watertown

08009

Teva Investigational Site 14754, Berlin

02865

Teva Investigational Site 14761, Lincoln

02886

Teva Investigational Site 14756, Warwick

602 00

Teva Investigational Site 54162, Brno

702 00

Teva Investigational Site 54165, Ostrava-Moravska

100 00

Teva Investigational Site 54163, Prague

130 00

Teva Investigational Site 54161, Prague

140 59

Teva Investigational Site 54164, Prague

160 00

Teva Investigational Site 54160, Prague

186 00

Teva Investigational Site 54166, Prague

00180

Teva Investigational Site 40034, Helsinki

00930

Teva Investigational Site 40035, Helsinki

FI-33100

Teva Investigational Site 40033, Tampere

06000

Teva Investigational Site 35240, Nice

D-10435

Teva Investigational Site 32690, Berlin

06120

Teva Investigational Site 32691, Halle

00128

Teva Investigational Site 30204, Roma

1078VV

Teva Investigational Site 38126, Amsterdam

1261 AN

Teva Investigational Site 38127, Blaricum

2333 ZA

Teva Investigational Site 38124, Leiden

5042 AD

Teva Investigational Site 38125, Tilburg

31-209

Teva Investigational Site 53420, Krakow

33-332

Teva Investigational Site 53425, Krakow

90-338

Teva Investigational Site 53422, Lodz

90-368

Teva Investigational Site 53424, Lodz

20-022

Teva Investigational Site 53418, Lublin

60-529

Teva Investigational Site 53416, Poznan

70-111

Teva Investigational Site 53419, Szczecin

00-909

Teva Investigational Site 53417, Warsaw

04-730

Teva Investigational Site 53423, Warsaw

08035

Teva Investigational Site 31231, Barcelona

252 20

Teva Investigational Site 42050, Helsingborg

141 86

Teva Investigational Site 42049, Huddinge

260 83

Teva Investigational Site 42051, Lund

112 81

Teva Investigational Site 42052, Stockholm

114 33

Teva Investigational Site 42054, Stockholm

G51 4TF

Teva Investigational Site 34231, Glasgow

HU3 2JZ

Teva Investigational Site 34232, Hull

SE5 9NT

Teva Investigational Site 34233, London

OX3 9DU

Teva Investigational Site 34230, Oxford

M6 8HD

Teva Investigational Site 34235, Salford

ST4 6QG

Teva Investigational Site 34236, Stoke-on-Trent

All Listed Sponsors
lead

Teva Branded Pharmaceutical Products R&D, Inc.

INDUSTRY

NCT03308968 - An Efficacy and Safety Study of Fremanezumab in Adults With Migraine | Biotech Hunter | Biotech Hunter